Pharmacokinetic Variability of Amikacin After Once-Daily and Twice-Daily Dosing Regimen in Full-Term Neonates

Pharmacokinetic Variability of Amikacin After Once-Daily and Twice-Daily Dosing Regimen in Full-Term Neonates

The purpose of the study was to compare peak (Cpeak) and trough (Ctrough) amikacin levels after twice-daily (TD) or once-daily dosing (OD) in full-term neonates. Additionally, the study aimed to address amikacin pharmacokinetics and its variability. Data included 31 patients born on term. Amikacin d...

Full description

Bibliographic Details
Main Authors:	Katarina Vučićević, Zorica Rakonjac, Branislava Miljković, Borisav Janković, Milica Prostran
Format:	Article
Language:	English
Published:	Elsevier 2014-01-01
Series:	Journal of Pharmacological Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861319301963

Similar Items

Clinical pharmacokinetics in optimal gentamicin dosing regimen in neonates
by: Vučićević Katarina, et al.
Published: (2014-06-01)

Efficacy and toxicity of once versus twice daily regimens of amikacin in febrile neutropenic pediatric cancer patients
by: Reda Abd-Elfattah, et al.
Published: (2017-03-01)

Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial
by: Balk JM, et al.
Published: (2015-08-01)

Fertility of dairy cows milked once daily or twice daily in New Zealand
by: J.M.D.R. Jayawardana, et al.
Published: (2022-11-01)

Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials.
by: Matthew E Falagas, et al.
Published: (2015-01-01)

Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease
by: Sakai Y, et al.
Published: (2013-10-01)

A randomized trial of once daily versus twice daily dosing of oral iron in CKD
by: Vivek Sood, et al.
Published: (2023-01-01)

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.
by: Catherine G Derington, et al.
Published: (2020-01-01)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
by: Woodcock Ashley, et al.
Published: (2011-12-01)

Exploring sirolimus pharmacokinetic variability using data available from the routine clinical care of renal transplant patients: Population pharmacokinetic approach
by: Golubović Bojana, et al.
Published: (2019-01-01)

Pharmacokinetics and Efficacy of Fluvoxamine and Amitriptyline in Depression
by: Sandra Vezmar, et al.
Published: (2009-01-01)

Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis
by: Mads Lamm Larsen, et al.
Published: (2019-04-01)

Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan
by: Ipoly Szauder, et al.
Published: (2015-07-01)

Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum]
by: Shen J, et al.
Published: (2018-08-01)

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.
by: Musiime, V, et al.
Published: (2010)

Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
by: Nachega JB, et al.
Published: (2011-12-01)

Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13).
by: Bergshoeff, A, et al.
Published: (2005)

Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with type 2 diabetes
by: Bethel, M, et al.
Published: (2016)

Once-daily versus twice-daily enoxaparin for the initial treatment of acute deep venous thrombosis: a case–control study
by: Mohamad T Yusuf, et al.
Published: (2019-01-01)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
by: Jong Man Kim, et al.
Published: (2021-09-01)

Once-daily or twice-daily delivery of inhaled corticosteroids: assessment of the efficacy and of influence of the long term treatment on growth in asthmatic children
by: Lilijana Besednjak-Kocijančič
Published: (2006-03-01)

COMPARISON OF EFFICACY AND SAFETY SILODOSIN 8 MG ONCE DAILY AND SILODOSIN 4 MG TWICE DAILY IN BPH PATIENTS WITH LUTS
by: Ramzie Nendra Diansyah, et al.
Published: (2019-01-01)

HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens
by: Shashi N Kapadia, et al.
Published: (2018-12-01)

Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial
by: Musiime, V, et al.
Published: (2016)

Twice- or once-daily dosing of direct oral anticoagulants and gastrointestinal bleeding in patient with atrial fibrillation
by: Tadakiyo Ido, et al.
Published: (2022-10-01)

Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia
by: Hideo Kato, et al.
Published: (2022-07-01)

Effects of Late Conversion from Twice-Daily to Once-Daily Slow Release Tacrolimus on the Insulin Resistance Indexes in Kidney Transplant Patients
by: Valeria Cademartori, et al.
Published: (2021-02-01)

The effect of Maintenance Treatment with Twice-daily or Prolonged Once-daily Tacrolimus Formulation on Visual Evoked Potentials in Stable Kidney Transplant Recipients
by: Aureliusz Kolonko, et al.
Published: (2020-06-01)

Efficacy and safety of latanoprost/timolol fixed combination dosed twice daily compared to once daily in patients with primary open angle glaucoma
by: Anis Baidura Azal, et al.
Published: (2023-08-01)

A Phase I Randomized Trial of Once‐Daily Versus Twice‐Daily Recombinant Human Parathyroid Hormone (1‐84) for Hypoparathyroidism
by: Steven W. Ing, et al.
Published: (2023-07-01)

Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy
by: Mody R, et al.
Published: (2013-04-01)

Once and Twice
by: Richard S. Kayne
Published: (2015-05-01)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
by: Notter Marianne, et al.
Published: (2008-03-01)

An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.
by: Connolly, M, et al.
Published: (2009)

ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
by: YiHong, S, et al.
Published: (2013)

Heritabilities and genetic and phenotypic correlations for milk production and fertility traits of spring-calved once-daily or twice-daily milking cows in New Zealand
by: J.M.D.R. Jayawardana, et al.
Published: (2023-03-01)

Tacrolimus dose adjustment is not necessary in dose to dose conversion from a twice daily to a prolonged release once daily dose form
by: Kanitha Tiankanon, et al.
Published: (2022-06-01)

Efficacy of twice-daily vs once-daily sessions of repetitive transcranial magnetic stimulation in the treatment of major depressive disorder: a retrospective study
by: Modirrousta M, et al.
Published: (2018-01-01)

Clinical Pharmacokinetics of Amikacin in Neonates
by: Gian Maria Pacifici, et al.
Published: (2017-02-01)

Electronic monitoring of adherence to once‐daily and twice‐daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP‐AF trial
by: Tsuyoshi Shiga, et al.
Published: (2021-06-01)